Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis

Background/Aims: The global proportion of hepatocellular carcinoma (HCC) attributable to metabolic dysfunction-associated fatty liver disease (MAFLD) is unclear. The MAFLD diagnostic criteria allows objective diagnosis in the presence of steatosis plus defined markers of metabolic dysfunction, irres...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian‐Hong Zhong, Gianluca Svegliati‐Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone I. Strasser, Jacob George
Médium: Revisão
Jazyk:angličtina
Vydáno: 2024
On-line přístup:https://doi.org/10.3350/cmh.2024.0109
https://www.e-cmh.org/upload/pdf/cmh-2024-0109.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!